ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CARA Cara Therapeutics Inc

0.6843
-0.0157 (-2.24%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0157 -2.24% 0.6843 08:11:01
Open Price Low Price High Price Close Price Previous Close
0.69 0.68 0.7264 0.6843 0.70
more quote information »

Recent News

Date Time Source Heading
02/4/202422:00GLOBECara Therapeutics to Present at the 23rd Annual Needham..
07/3/202423:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
07/3/202408:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:10EDGAR2Form 8-K - Current report
05/3/202408:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
14/2/202410:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202409:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202409:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202408:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
06/2/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:59EDGAR2Form 8-K - Current report
30/1/202407:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202408:19EDGAR2Form 8-K - Current report
22/1/202423:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
18/12/202323:10EDGAR2Form 8-K - Current report
18/12/202323:00GLOBECara Therapeutics Announces Outcome from Dose-Finding Part A..
14/11/202308:28EDGAR2Form 8-K - Current report
14/11/202308:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:11EDGAR2Form 8-K - Current report
14/11/202308:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
04/11/202307:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202322:10EDGAR2Form 8-K - Current report
02/11/202322:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
23/10/202322:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
25/9/202321:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
05/9/202321:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
08/8/202306:24EDGAR2Form 8-K - Current report
08/8/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:10EDGAR2Form 8-K - Current report
08/8/202306:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
05/8/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202307:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202321:06EDGAR2Form 8-K - Current report
03/8/202321:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
02/8/202321:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
26/7/202306:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/7/202321:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
03/6/202308:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
01/6/202321:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
18/5/202316:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
16/5/202306:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock